Synthesis and gastric antisecretory properties of alpha chain diene derivatives of misoprostol. 1986

P W Collins, and A F Gasiecki, and P H Jones, and R F Bauer, and G W Gullikson, and E M Woods, and R G Bianchi

The synthesis and gastric antisecretory activity in dogs of seven alpha chain diene derivatives of misoprostol are described. The key intermediates in the preparation of these compounds were C-9 tert-butyldimethylsilyl enol ethers that were obtained by in situ silylation of cuprate enolates derived from alpha chain unsaturated cyclopentenones. Selenylation chemistry on these intermediates provided the C2-C3 trans dienes that, where possible, were also deconjugated to produce the corresponding C3-C4 dienes. The most interesting structure in this series is the C5-C6 cis, C3-C4 cis/trans (1:1) diene that could not be readily separated chromatographically into its individual geometric isomers. The gastric antisecretory activity of the mixture of isomers was approximately 3 times greater than that of misoprostol by intragastric administration. The separation of undesired diarrheogenic effects from antisecretory activity was significantly improved relative to misoprostol.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D005750 Gastric Juice The liquid secretion of the stomach mucosa consisting of hydrochloric acid (GASTRIC ACID); PEPSINOGENS; INTRINSIC FACTOR; GASTRIN; MUCUS; and the bicarbonate ion (BICARBONATES). (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p651) Gastric Juices,Juice, Gastric,Juices, Gastric
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

P W Collins, and A F Gasiecki, and P H Jones, and R F Bauer, and G W Gullikson, and E M Woods, and R G Bianchi
March 1971, Journal of medicinal chemistry,
P W Collins, and A F Gasiecki, and P H Jones, and R F Bauer, and G W Gullikson, and E M Woods, and R G Bianchi
January 1987, Prostaglandins,
P W Collins, and A F Gasiecki, and P H Jones, and R F Bauer, and G W Gullikson, and E M Woods, and R G Bianchi
April 1989, DICP : the annals of pharmacotherapy,
P W Collins, and A F Gasiecki, and P H Jones, and R F Bauer, and G W Gullikson, and E M Woods, and R G Bianchi
May 1991, Digestive diseases and sciences,
P W Collins, and A F Gasiecki, and P H Jones, and R F Bauer, and G W Gullikson, and E M Woods, and R G Bianchi
December 1984, Chemical & pharmaceutical bulletin,
P W Collins, and A F Gasiecki, and P H Jones, and R F Bauer, and G W Gullikson, and E M Woods, and R G Bianchi
September 1977, Journal of medicinal chemistry,
P W Collins, and A F Gasiecki, and P H Jones, and R F Bauer, and G W Gullikson, and E M Woods, and R G Bianchi
July 1984, Archives internationales de pharmacodynamie et de therapie,
P W Collins, and A F Gasiecki, and P H Jones, and R F Bauer, and G W Gullikson, and E M Woods, and R G Bianchi
October 1989, Chemical & pharmaceutical bulletin,
P W Collins, and A F Gasiecki, and P H Jones, and R F Bauer, and G W Gullikson, and E M Woods, and R G Bianchi
December 1987, Journal of medicinal chemistry,
P W Collins, and A F Gasiecki, and P H Jones, and R F Bauer, and G W Gullikson, and E M Woods, and R G Bianchi
August 1989, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!